HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Significant recovery of motor function in a patient with complete T7 paraplegia receiving etanercept.

AbstractOBJECTIVE:
To report an unusual case of significant motor recovery in a patient with T7 complete paraplegia treated with etanercept for ankylosing spondylitis.
DESIGN:
Case report.
RESULTS:
During the first year sensory-motor recovery occurred, and the American Spinal Injury Association Impairment Scale (AIS) improved from A to D.
CONCLUSION:
Initial spinal cord injury is a direct consequence of the trauma. It triggers a series of molecular and cellular reactions leading to "secondary damage". Tumour necrosis factor alpha is a key inflammatory mediator that is increasingly expressed after spinal cord injury. Etanercept is a recombinant dimer of human tumour necrosis factor alpha receptor protein that inhibits tumour necrosis factor alpha activity. It has shown an immunomodulatory effect in mice after traumatic spinal cord injury. It significantly reduced the post-traumatic spinal cord inflammation and the perilesional area. In this case, a reduction in the secondary damage, due to etanercept treatment could explain the significant motor recovery, which is unusual since 80% of AIS A lesions remain complete.
AuthorsMickaël Dinomais, Laura Stana, Guy Egon, Isabelle Richard, Philippe Menei
JournalJournal of rehabilitation medicine (J Rehabil Med) Vol. 41 Issue 4 Pg. 286-8 (Mar 2009) ISSN: 1651-2081 [Electronic] Sweden
PMID19247551 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunoglobulin G
  • Immunologic Factors
  • Receptors, Tumor Necrosis Factor
  • Etanercept
Topics
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G (therapeutic use)
  • Immunologic Factors (therapeutic use)
  • Magnetic Resonance Imaging
  • Neurologic Examination
  • Paraplegia (drug therapy, physiopathology, rehabilitation)
  • Radiography
  • Receptors, Tumor Necrosis Factor (therapeutic use)
  • Recovery of Function
  • Spinal Cord (diagnostic imaging, pathology)
  • Spinal Cord Injuries (drug therapy, physiopathology, rehabilitation)
  • Spondylitis, Ankylosing (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: